Regulation of Lysyl Oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 11, 2011, Pages 8488-8495

  Zenkel, Matthias ^a   Krysta, Anita ^a   Pasutto, Francesca ^a   Juenemann, Anselm ^a   Kruse, Friedrich E ^a   Schlötzer Schrehardt, Ursula ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN; FIBRILLIN; HOMOCYSTEINE; INTERLEUKIN 6; MESSENGER RNA; PROTEIN LYSINE 6 OXIDASE; TRANSFORMING GROWTH FACTOR BETA1; HYDROGEN PEROXIDE; LOXL1 PROTEIN, HUMAN; OXIDOREDUCTASE;

AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; ELASTIN RELATED GENE; FEMALE; FIBROBLAST; GENE; GENETIC RISK; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; LYSYL OXIDASE LIKE 1 GENE; MALE; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PSEUDOEXFOLIATION; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET RADIATION; UPREGULATION; WESTERN BLOTTING; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ELECTRON MICROSCOPY; EXFOLIATION SYNDROME; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; METABOLISM; PHYSIOLOGY; RADIATION EXPOSURE; TENON CAPSULE;

AGED, 80 AND OVER; AMINO ACID OXIDOREDUCTASES; BLOTTING, WESTERN; CELLS, CULTURED; ELASTIN; EXFOLIATION SYNDROME; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; GENOTYPE; HOMOCYSTEINE; HUMANS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TENON CAPSULE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84855986689     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8361     Document Type: Article

References (45)

1. Schlötzer-Schrehardt U, Naumann GOH. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol. 2006;141:921-937.
2. Ritch R. Exfoliation syndrome: the most common identifiable cause of open-angle glaucoma. J Glaucoma. 1996;3:176-178.
3. Gottanka J, Flügel-Koch C, Martus P, Johnson DH, Lütjen-Drecoll E. Correlation of pseudoexfoliative material and optic nerve damage in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 1997; 38:2435-2446.
4. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45:265-315.
5. Schlötzer-Schrehardt U, Pasutto F, Sommer P, et al. Genotypecorrelated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. Am J Pathol. 2008;173:1724-1735.
6. Ovodenko B, Rostagno A, Neubert TA, et al. Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci. 2007;48:1447-1457.
7. Sharma S, Chataway T, Burdon KP, et al. Identification of LOXL1 protein and apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry. Exp Eye Res. 2009;89:479-485.
8. Liu X, Zhao Y, Gao J, et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet. 2004;36:178-182.
9. Schlötzer-Schrehardt U. Genetics and genomics of pseudoexfoliation syndrome/glaucoma. Middle East Afr J Ophthalmol. 2011;18: 30-36.
10. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317:1397-1400.
11. Chen H, Chen LJ, Zhang M, et al. Ethnicity-based subgroup metaanalysis of the association of LOXL1 polymorphisms with glaucoma. Mol Vis. 2010;16:167-177.
12. Pasutto F, Krumbiegel M, Mardin CY, et al. Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1459-1463.
13. Burdon KP, Sharma S, Hewitt AW, et al. Genetic analysis of the clusterin gene in pseudoexfoliation syndrome. Mol Vis. 2008;14: 1727-1736.
14. Krumbiegel M, Pasutto F, Mardin CY, et al. Exploring functional candidate genes for genetic association in German patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci. 2009;50:2796-2801.
15. Krumbiegel M, Pasutto F, Schlötzer-Schrehardt U, et al. Genomewide association study with DNA pooling identifies variants at CNTNAP2 associated with pseudoexfoliation syndrome. Eur J Hum Genet. 2011;19:186-193.
16. 2A and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol. 2003;87:353-356.
17. Helbig H, Schlötzer-Schrehardt U, Noske W, Kellner U, Foerster MH, Naumann GOH. Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. Ger J Ophthalmol. 1994;3:148-153.
18. Taylor HR, Hollows FC, Moran D. Pseudoexfoliation of the lens in Australian Aborigines. Br J Ophthalmol. 1977;61:473-475.
19. Schlötzer-Schrehardt U, Zenkel M, Küchle M, Sakai LY, Naumann GOH. Role of transforming growth factor-β and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res. 2001;73:765-780.
20. Zenkel M, Lewczuk P, Jünemann AG, Kruse FE, Naumann GO, Schlötzer-Schrehardt U. Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. Am J Pathol. 2010;176:2868-2879.
21. Bleich S, Roedl J, Von Ahsen N, et al. Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol. 2004;138:162-164.
22. Smith-Mungo LI, Kagan HM. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 1998;16:387-398.
23. Decitre M, Gleyzal C, Raccurt M, et al. Lysyl oxidase-like protein localizes to sites of de novo fibrinogenesis in fibrosis and in the early stromal reaction of ductal breast carcinomas. Lab Invest. 1998;78:143-151.
24. Schlötzer-Schrehardt U, Zenkel M, Decking U, et al. Selective upregulation of the A3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma. Invest Ophthalmol Vis Sci. 2005;46:2023-2034.
25. Heller S, Mayer UM. Effect of UV-A light on the catalase activity in the vitreous body of calf eyes. Ger J Ophthalmol. 1994;3:445-446.
26. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers In: Krawetz S, Misener S, eds. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Humana Press; 2000:365-386.
27. Damji KF, Bains HS, Stefansson E, et al. Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation. Ophthalmic Genet. 1998;19:175-185.
28. Wiggs JL. Association between LOXL1 and pseudoexfoliation. Arch Ophthalmol. 2008;126:420-421.
29. Fan BJ, Pasquale LR, Rhee D, Li T, Haines JL, Wiggs JL. LOXL1 promoter haplotypes are associated with exfoliation syndrome in a U.S. Caucasian population. Invest Ophthalmol Vis Sci. 2011;52: 2372-2378.
30. Schlötzer-Schrehardt U. Molecular pathology of pseudoexfoliation syndrome/glaucoma: new insights from LOXL1 gene associations. Exp Eye Res. 2009;88:776-785.
31. Roberts AB, Heine UI, Flanders KC, Sporn MB. Transforming growth factor-beta. Major role in regulation of extracellular matrix. Ann NY Acad Sci. 1990;580:225-232.
32. Kliment CR, Oury TD. Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis. Free Radic Biol Med. 2010;49:707-717.
33. Gu W, Liu W, Yang X, et al. Effects of intense pulsed light and ultraviolet A on metalloproteinases and extracellular matrix expression in human skin. Photomed Laser Surg. 2011;29:97-103.
34. Myllyharju J, Schipani E. Extracellular matrix genes as hypoxiainducible targets. Cell Tissue Res. 2010;339:19-29.
35. Tyagi SC. Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. Am J Physiol Cell Physiol. 1998;274:C396-C405.
36. Sethi A, Mao W, Wordinger RJ, Clark AF. Transforming growth factor beta induces extracellular matrix protein cross-linking lysyl oxidase (LOX) genes in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2011;52:5240-5250.
37. Gacheru SN, Thomas KM, Murray SA, Csiszar K, Smith-Mungo LI, Kagan HM. Transcriptional and post-transcriptional control of lysyl oxidase expression in vascular smooth muscle cells: effects of TGF-beta 1 and serum deprivation. J Cell Biochem. 1997;65:395-407.
38. Voloshenyuk TG, Landesman ES, Khoutorova E, Hart AD, Gardner JD. Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling. Cytokine. 2011;55:90-97.
39. Majora M, Wittkampf T, Schuermann B, et al. Functional consequences of mitochondrial DNA deletions in human skin fibroblasts: increased contractile strength in collagen lattices is due to oxidative stress-induced lysyl oxidase activity. Am J Pathol. 2009;175:1019-1029.
40. van Vlimmeren MA, Driessen-Mol A, van den Broek M, Bouten CV, Baaijens FP. Controlling matrix formation and cross-linking by hypoxia in cardiovascular tissue engineering. J Appl Physiol. 2010; 109:1483-1491.
41. Kirwan RP, Fenerty CH, Crean J, Wordinger RJ, Clark AF, O'Brien CJ. Influence of cyclical mechanical strain on extracellular matrix gene expression in human lamina cribrosa cells in vitro. Mol Vis. 2005;11:798-810.
42. Raposo B, Rodríguez C, Martínez-González J, Badimon L. High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells. Atherosclerosis. 2004;177:1-8.
43. Coral K, Angayarkanni N, Gomathy N, Bharathselvi M, Pukhraj R, Rupak R. Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase. Invest Ophthalmol Vis Sci. 2009; 50:3607-3612.
44. Rodríguez C, Rodríguez-Sinovas A, Martínez-González J. Lysyl oxidase as a potential therapeutic target. Drug News Perspect. 2008; 21:218-224.
45. Hong HH, Trackman PC. Cytokine regulation of gingival fibroblast lysyl oxidase, collagen, and elastin. J Periodontol. 2002;73:145-152.